Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of concomitant sIPV and DTaP vaccination in healthy infants
ChiCTR2100042116Phase 4Recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sabin strain inactivated poliovirus vaccine and diphtheria, tetanus, and acellular pertussis vaccine in poliomyelitis, pertussis, diphtheria and 1 more (3 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Antibody positive rate, Seroconversion rate and 2 more. Started Jun 2019; status: recruiting.
02
Drugs
Sabin strain inactivated poliovirus vaccinediphtheria, tetanus, and acellular pertussis vaccine
03
Conditions
poliomyelitispertussisdiphtheriaTetanus
Beyond the preview
Go deeper on ChiCTR2100042116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042116.